行情

SPPI

SPPI

光谱制药
NASDAQ

实时行情|Nasdaq Last Sale

8.65
-0.04
-0.46%
盘后: 8.65 0 0.00% 16:00 11/21 EST
开盘
8.75
昨收
8.69
最高
8.93
最低
8.49
成交量
56.18万
成交额
--
52周最高
14.65
52周最低
6.22
市值
9.77亿
市盈率(TTM)
-6.5052
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SPPI 新闻

  • Top Small Cap Stocks for November 2019
  • Investopedia.3天前
  • Edited Transcript of SPPI earnings conference call or presentation 7-Nov-19 9:30pm GMT
  • Thomson Reuters StreetEvents.5天前
  • Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2019 London Healthcare Conference on November 21st
  • Business Wire.11/14 12:00
  • Spectrum Pharmaceuticals, Inc. (SPPI) CEO Joseph Turgeon on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/11 01:38

更多

所属板块

生物技术和医学研究
-0.38%
制药与医学研究
+0.29%

热门股票

名称
价格
涨跌幅

SPPI 简况

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company operates through developing and commercializing oncology and hematology drug products segment. It focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.
展开

Webull提供Spectrum Pharmaceuticals, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。